Cue Biopharma, Inc. (CUE) Insider Trading -- Recent Executive & Director Transactions

9 insiders reported 29 Form 4 transactions for Cue Biopharma, Inc. (CUE) over the past 18 months (most recent 2026-08-17). Recent activity: Ray Sumita (Chief Legal Compliance Officer) Buy 18,196 shares, Meluzio Michael Vincent (VP, Prin. Accounting Officer) Buy 13,647 shares, Ray Sumita (Chief Legal Compliance Officer) Sell 2,383 shares, Meluzio Michael Vincent (VP, Prin. Accounting Officer) Sell 1,519 shares, Ray Sumita (Chief Legal Compliance Officer) Sell 6,442 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-08-17Ray SumitaChief Legal Compliance OfficerBuy18,196$0
2026-08-17Meluzio Michael VincentVP, Prin. Accounting OfficerBuy13,647$0
2026-08-17Ray SumitaChief Legal Compliance OfficerSell2,383$69,989
2026-08-17Meluzio Michael VincentVP, Prin. Accounting OfficerSell1,519$44,613
2026-08-17Ray SumitaChief Legal Compliance OfficerSell6,442$195,515
2026-08-17Meluzio Michael VincentVP, Prin. Accounting OfficerSell4,106$124,617
2026-08-17Ray SumitaChief Legal Compliance OfficerSell4$125
2026-08-17Meluzio Michael VincentVP, Prin. Accounting OfficerSell3$93
2026-08-14Lin Shao-LeeChief Executive OfficerSell2,375$66,761
2026-08-14Lin Shao-LeeChief Executive OfficerSell34,225$923,733
2026-08-14Lin Shao-LeeChief Executive OfficerSell5,775$160,256
2026-08-14Lin Shao-LeeChief Executive OfficerSell5,423$147,451
2026-08-14Lin Shao-LeeChief Executive OfficerBuy109,179$0
2026-08-14Lin Shao-LeeChief Executive OfficerSell10,460$308,361
2026-08-03Ahlers James MChief Financial OfficerBuy25,500$0
2026-07-15Borie Dominique ChristianChief Medical OfficerBuy31,500$0
2026-07-10Ray SumitaChief Legal Compliance OfficerBuy54,589$0
2026-07-10Lin Shao-LeeChief Executive OfficerBuy327,537$0
2026-07-10Camardo Daniel A.DirectorBuy21,800$0
2026-07-10Garzone PamelaDirectorBuy21,800$0
2026-07-10Sarraf PashaDirectorBuy21,800$0
2026-07-10Meehan Viola MongDirectorBuy21,800$0
2026-07-10Meluzio Michael VincentVP, Prin. Accounting OfficerBuy40,942$0
2026-05-07Lin Shao-LeeCHIEF EXECUTIVE OFFICERBuy327,537$0
2026-01-02Sarraf PashaDirectorBuy4,229$1,311

Source: SEC Form 4 filings · as of 2026-08-17